Skip to content

Curvafix® Intramedullary System for Fixation of Pelvic and Acetabular Fractures, A Post Market Evaluation

Curvafix® Intramedullary System for Fixation of Pelvic and Acetabular Fractures, A Post Market Performance Evaluation

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05606042
Enrollment
53
Registered
2022-11-04
Start date
2021-11-24
Completion date
2023-03-09
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acetabular Fracture, Pelvic Fracture, Pelvic Fracture Acetabulum, Pelvic Ring Fracture

Brief summary

Prospective, single arm, post-market evaluation to evaluate the use and performance of the IM Implant in a post market setting.

Detailed description

This study will evaluate the use and performance of the Curvafix IM intramedullary system for pelvic fixation in a post-market setting. Study participants will undergo follow-up care per institutional practice and data will then be collected from participant medical records. There will be no active patient participation requirements outside of standard of care. Any follow up evaluations will be documented and reported through 6 months post-implantation. The study will evaluate secondary surgical interventions as a primary study endpoint. Data will also be collected and analyzed for pelvic reduction stability, fracture healing, participant mobility/ambulation, and general health economics.

Interventions

DEVICEIM Implant

Patients that have had surgical interventions with one or more IM Implant as part of standard of care for a pelvic and/or acetabular fracture

Sponsors

CurvaFix, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subject, or their Authorized Representative, is willing and able to provide written informed consent, including authorization to release health information * Subject has undergone pelvic or acetabular fixation using the IM Implant and the IM Implant was placed according to the manufacturer's labeling. * Subject's pelvic or acetabular fixation with the IM Implant occurred within the last 30 calendar days.

Exclusion criteria

* Subject is unwilling or unable to provide written informed consent and/or does not have an authorized representative who can provide consent on their behalf * Subject presents with any condition or situation which, in the Investigator's opinion, puts the Subject at risk, could confound the study results, or may interfere with the Subject's participation in the study

Design outcomes

Primary

MeasureTime frameDescription
Secondary Surgical Interventions (SSIs)6 months post-implantationPerformance will be evaluated based upon the number of Secondary Surgical Interventions (SSIs) that occur within the subject's participation as identified through a review of subject medical records.

Secondary

MeasureTime frameDescription
Mobility6 months post-implantationMobility (ability to advance to weight bearing) assessed by medical record review
Pelvic Reduction Stability6 months post-implantationPelvic reduction stability (ability to maintain reduction over time) assessed by medical record review
Health Economics6 months post-implantationGeneral health economics (length of hospital stay) assessed by medical record review

Countries

United States

Contacts

STUDY_DIRECTORJennifer Hebert

Clin-Assist, LLC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026